DOCU vs TRI vs AEYE Stock Comparison

Docusign, Thomson Reuters and Audioeye Prices as of Oct 28, 2026 Peers: Industry group
1 more company in this comparison (CLVT) Create a free account to keep reading and compare up to 10 companies.
DOCU Docusign, Inc.
$83.60 +24.8% 1M +18.2% 1Y
Market cap
$15.73B
P/E
48.5x
Revenue (TTM)
$3.36B
Div. yield
–
Compliance Software Technology
4 wins
TRI Thomson Reuters Corp /Can/
$116.09 +19.3% 1M -28.3% 1Y
Market cap
$51.66B
P/E
32.1x
Revenue (TTM)
$7.83B
Div. yield
3.47%
Compliance Software Technology
4 wins
AEYE Audioeye Inc
$11.94 +76.1% 1M -17.5% 1Y
Market cap
$151.35M
P/E
–
Revenue (TTM)
$42.73M
Div. yield
–
Compliance Software Technology
2 wins

Head to Head

10 decided of 12

Thomson Reuters leads on 4 of the 12 questions below (Thomson Reuters 4, Docusign 4, Audioeye 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDOCUTRIAEYELeader
Larger companyMarket capitalisation $15.73B $51.66B $151.35M TRI
Cheaper on earningsLower P/E, profitable companies only 48.5x 32.1x -49.4x TRI
Cheaper on forward earningsLower price / next fiscal year consensus EPS 18.9x 26.0x 12.6x AEYE
Faster revenue growthRevenue growth, trailing twelve months +8.6% +7.0% +8.1% DOCU
More profitableNet margin, trailing twelve months 9.8% 20.7% -7.1% TRI
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — 1.2x 3.6x TRI
Higher dividend yieldTrailing dividend yield — 3.47% — –
Better 1-year returnPrice return, last 12 months +18.2% -28.3% -17.5% DOCU
Better 5-year returnAnnualised price return, 5 years -21.4%/yr -1.5%/yr +3.7%/yr AEYE
Less volatileAnnualised volatility, 1 year 48.5% 51.8% 80.5% DOCU
Higher overall scoreMean of the five percentile scores vs peers 72/100 56/100 47/100 DOCU

Percentile Scorecard

DOCUTRIAEYE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDOCUTRIAEYE
Valuation 68 #33 of 101 51 #50 of 101 41 #60 of 101
Growth 75 #25 of 97 25 #73 of 97 77 #23 of 97
Profitability 89 #11 of 94 99 #2 of 94 48 #49 of 94
Financial Health 54 #50 of 108 66 #37 of 108 33 #73 of 108
Shareholder Returns 73 #18 of 64 40 #39 of 64 33 #43 of 64
Overall 72 56 47
  • DOCU ranked among 114 companies in Business Applications
  • TRI ranked among 114 companies in Business Applications
  • AEYE ranked among 114 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDOCUTRIAEYESPY
1 month +24.8%+19.3%+76.1% +0.9%
3 months +43.7%+9.2%+108.7% +5.9%
6 months +78.2%+24.4%+64.2% +8.5%
Year to date +22.2%-12.0%+19.5% +13.3%
1 year +18.2%-28.3%-17.5% +12.4%
3 years +117.0%-1.5%+202.3% +88.1%
3 years, per year +29.5%-0.5%+44.6% +23.5%
5 years -70.0%-7.1%+20.1% +68.2%
5 years, per year -21.4%-1.5%+3.7% +11.0%
10 years —+183.1%+267.4% +263.4%
10 years, per year —+11.0%+13.9% +13.8%

Risk

MeasureDOCUTRIAEYESPY
Volatility, 1Y 48.5%51.8%80.5% 12.7%
Downside volatility, 1Y 48.6%52.4%69.2% 12.7%
Beta vs S&P 500, 1Y 0.460.161.99 1.00
Return / volatility, 1Y 0.38-0.55-0.22 0.98
Max drawdown, 5Y -86.4%-64.3%-83.9% -25.4%
From 52-week high -2.0%-28.3%-22.3% -0.9%
52-week high $85.27$161.88$15.37 $779.14
52-week low $41.75$76.55$5.40 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDOCUTRIAEYE
P/E now vs peer median 48.5xmedian 27.6x 32.1xmedian 27.6x -49.4xmedian 27.6x
P/S now vs peer median 4.7xmedian 2.7x 6.6xmedian 2.7x 3.5xmedian 2.7x
EV/EBITDA now vs peer median 18.7xmedian 17.4x 25.7xmedian 17.4x 82.6xmedian 17.4x
P/FCF now vs peer median 13.1xmedian 15.8x 16.2xmedian 15.8x 23.3xmedian 15.8x
P/B now vs peer median 9.2xmedian 3.2x 4.6xmedian 3.2x 29.8xmedian 3.2x
PEG now vs peer median 0.26median 0.84 3.10median 0.84 -1.80median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDOCUTRIAEYE
Revenue $3.36B $7.83B $42.73M
Gross profit $2.67B – $34.08M
Operating income $402.03M $2.33B -$2.04M
Net income $329.94M $1.68B -$3.04M
Free cash flow $1.20B $3.19B $6.51M
R&D $659.08M – $3.97M
EPS (diluted) $1.71 $3.61 $-0.23
Cash & equivalents $528.16M $577.00M $9.33M
Total debt – $3.26B $16.23M
Shares (diluted) 193.12M 449.53M 12.97M
Enterprise value $12.43B $48.44B $119.46M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDOCUTRIAEYE
P/E 48.5x 32.1x -49.4x
P/FCF 13.1x 16.2x 23.3x
P/Operating cash flow 11.9x 17.9x 23.0x
P/S 4.7x 6.6x 3.5x
P/B 9.2x 4.6x 29.8x
P/Tangible book 9.4x 6.4x -26.3x
EV/EBITDA 18.7x 25.7x 82.6x
EV/EBIT 37.2x 23.3x -77.6x
EV/Revenue 4.4x 6.9x 3.7x
EV/FCF 12.5x 17.0x 24.3x
EV/Operating cash flow 11.3x 18.8x 24.1x
PEG (3Y EPS CAGR) 0.26 3.10 -1.80

Growth

14 metrics
MetricDOCUTRIAEYE
Revenue growth (1Y) 8.6% 7.0% 8.1%
Revenue CAGR (3Y) 8.2% 5.2% 11.1%
Gross profit growth (1Y) 8.8% – 9.6%
Gross profit CAGR (3Y) 8.3% – 12.1%
Operating income growth (1Y) 64.1% 9.1% 10.8%
Operating income CAGR (3Y) 160.2% -0.5% 34.9%
Net income growth (1Y) 17.4% 4.7% 13.4%
Net income CAGR (3Y) 177.3% -6.8% 25.2%
EPS growth (1Y) 28.3% 8.4% 17.2%
EPS CAGR (3Y) 183.7% 10.4% 27.5%
Operating cash flow growth (1Y) 27.3% 14.5% 135.8%
Operating cash flow CAGR (3Y) 27.8% 10.1% 103.5%
Free cash flow growth (1Y) 28.1% 13.0% 139.4%
Free cash flow CAGR (3Y) 29.9% 9.0% 93.7%

Profitability

14 metrics
MetricDOCUTRIAEYE
Gross margin 79.5% – 79.8%
EBITDA margin 23.7% 26.9% 4.5%
Operating margin 12.0% 29.7% -4.8%
Pretax margin 13.1% 46.5% -4.8%
Net margin 9.8% 20.7% -7.1%
FCF margin 35.7% 40.7% 15.2%
Operating cash flow margin 39.4% 36.9% 15.4%
Return on equity 18.6% – -49.2%
Return on assets 8.3% – -5.9%
Return on invested capital – – –
Return on capital employed 20.1% – -9.5%
Asset turnover 0.8x – 1.2x
Cash conversion (OCF / net income) 4.0x 1.7x -2.2x
Stock comp / revenue 15.3% – 11.7%

Financial Health

11 metrics
MetricDOCUTRIAEYE
Debt / assets – 18.0% 47.8%
Debt / equity – 0.3x 3.2x
Net debt / EBITDA – 1.2x 3.6x
Debt / FCF – 1.0x 2.5x
Liabilities / assets 56.6% 38.5% 85.0%
Equity / assets 43.4% 61.5% 15.0%
Interest coverage 170.4x 116.5x –
Current ratio 0.6x 0.5x 1.2x
Quick ratio 0.6x -2.5x 1.2x
Cash ratio 0.4x 0.2x 0.7x
Altman Z-score 4.36 5.87 -0.05

Shareholder Returns

7 metrics
MetricDOCUTRIAEYE
Dividend yield – 3.5% –
Net buyback yield 6.8% -2.2% 0.9%
Shareholder yield 6.8% 1.2% 0.9%
Payout ratio (earnings) – 30.9% –
Payout ratio (FCF) – 16.3% –
Dividend growth (1Y) – -10.6% –
Dividend CAGR (3Y) – -8.5% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDOCUTRIAEYE
Forward P/E 18.9xFY2026 26.0xFY2026 12.6xFY2026
EPS, next fiscal year $4.43FY2026 $4.47FY2026 $0.95FY2026
EPS growth, next FY +15.4%FY2026 +12.6%FY2026 +31.9%FY2026
EPS growth, the year after +12.6% +8.1% +31.6%
Revenue, next fiscal year $3.62BFY2026 $7.73BFY2026 $45.31MFY2026
Revenue growth, next FY +12.4%FY2026 +3.8%FY2026 +12.4%FY2026
Revenue growth, the year after -0.2% +15.5% +2.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDOCUTRIAEYE
Held by institutions 90.0% 90.1% 34.0%
Institutions holding 670 421 87
Change in shares held, QoQ -1.2% +0.6% -3.0%
Institutions buying 329 408 52
Institutions selling 243 9 24
Buyers to sellers 1.35 45.33 2.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DOCUTRIAEYE
DOCU 1.00 0.58 0.23
TRI 0.58 1.00 0.16
AEYE 0.23 0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DOCU, TRI and AEYE?

Thomson Reuters (TRI) is the largest by market capitalisation: Docusign (DOCU) $15.73B, Thomson Reuters (TRI) $51.66B, Audioeye (AEYE) $151.35M.

Which stock is cheaper, DOCU, TRI and AEYE?

Thomson Reuters (TRI) trades on the lowest price-to-earnings ratio (Docusign (DOCU) 48.5x, Thomson Reuters (TRI) 32.1x, Audioeye (AEYE) -49.4x). On next year's consensus earnings, Audioeye (AEYE) is cheapest (Docusign (DOCU) 18.9x, Thomson Reuters (TRI) 26.0x, Audioeye (AEYE) 12.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Docusign (DOCU) grew revenue fastest over the trailing twelve months: Docusign (DOCU) +8.6%, Thomson Reuters (TRI) +7.0%, Audioeye (AEYE) +8.1%.

Which company is more profitable?

Thomson Reuters (TRI) has the highest net margin (Docusign (DOCU) 9.8%, Thomson Reuters (TRI) 20.7%, Audioeye (AEYE) -7.1%).

Which stock has performed better?

Over the past year Docusign (DOCU) returned the most: Docusign (DOCU) +18.2%, Thomson Reuters (TRI) -28.3%, Audioeye (AEYE) -17.5%. Over five years, Audioeye (AEYE) compounded fastest (Docusign (DOCU) -21.4%/yr, Thomson Reuters (TRI) -1.5%/yr, Audioeye (AEYE) +3.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Thomson Reuters (TRI) 3.47%. Docusign (DOCU) and Audioeye (AEYE) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Docusign (DOCU) has been the steadiest (Docusign (DOCU) 48.5%, Thomson Reuters (TRI) 51.8%, Audioeye (AEYE) 80.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, DOCU, TRI and AEYE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Thomson Reuters (TRI) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.